Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-Week, Double-Blind Trial of Olanzapine and Placebo in the Treatment of Trichotillomania

NCT00182507 is registered in ClinicalTrials.gov with Hamilton Health Sciences Corporation as lead sponsor.

NCT NCT00182507
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00182507 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-Week, Double-Blind Trial of Olanzapine and Placebo in the Treatment of Trichotillomania
Lead sponsor
Hamilton Health Sciences Corporation
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2000
Completion date
March 31, 2006
Enrollment
34
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

trichotillomania